Skip to content

Betamethasone Dipropionate

Betamethasone dipropionate is a topical corticosteroid that reduces skin redness, swelling and itching. The catalogue has no single-ingredient record for it. Instead, each attached tube adds a different active ingredient for a different skin context.

Lotrisone

Tinea Cruris, Tinea Corporis, Tinea Pedis

10gr · 20gr

Formulated to alleviate inflamed fungal skin infections to support dermal clearance and target local fungal structures.

From$5.00/ tubeView

Wynzora

Plaque Psoriasis

15g

Developed to mitigate local plaque psoriasis to support skin cell normalisation and alleviate regional tissue inflammation.

From$55.20/ tubeView

Key points

  • Betamethasone dipropionate is a potent topical corticosteroid ingredient.
  • Lotrisone pairs it with the antifungal clotrimazole.
  • Wynzora pairs it with the vitamin D analogue calcipotriol.
  • Treated area, duration and occlusion affect topical corticosteroid exposure.

Lotrisone: an antifungal partner

Lotrisone is represented in 10 g and 20 g tubes. Clotrimazole addresses susceptible fungi, while betamethasone dipropionate suppresses inflammation. Its attached tinea topics place it in antifungals as well as women’s health.

The two ingredients should be read together. Suppressing redness alone can obscure a worsening infection, which is one reason combined antifungal and corticosteroid products have their own duration and application restrictions.

Wynzora: a psoriasis partner

Wynzora is a 15 g tube containing calcipotriol with betamethasone dipropionate. It connects with plaque psoriasis in skin care. Calcipotriol acts through vitamin D pathways, creating a clinical identity unrelated to Lotrisone’s antifungal component.

Topical betamethasone can be absorbed through skin. Large treated areas, prolonged use, damaged skin or covering the area can increase exposure and adverse effects. This product-specific context is more useful than treating every corticosteroid tube as the same item.

Further reading